Skip to main content

Table 3 Use of vasopressors over time between the treated and control groups

From: Effectiveness of anisodamine for the treatment of critically ill patients with septic shock: a multicentre randomized controlled trial

 

Any vasopressor

Dopamine

Epinephrine

OR [95% CI]

p

OR [95% CI]

p

OR [95% CI]

p

Day 0

0.29 [0.04, 1.22]

0.125

0.82 [0.43, 1.55]

0.532

0.96 [0.53, 1.73]

0.884

Day 1

0.89 [0.41, 1.94]

0.776

0.75 [0.34, 0.94]

0.048

1.05 [0.59, 1.86]

0.872

Day 2

0.80 [0.48, 1.35]

0.410

0.55 [0.23, 0.91]

0.039

0.98 [0.61, 1.56]

0.933

Day 3

0.74 [0.48, 1.15]

0.183

0.45 [0.15, 0.88]

0.021

0.90 [0.58, 1.39]

0.635

Day 4

0.76 [0.48, 1.21]

0.249

0.42 [0.13, 0.82]

0.012

0.98 [0.61, 1.58]

0.944

Day 5

0.84 [0.50, 0.93]

0.041

0.66 [0.17, 2.35]

0.523

0.88 [0.50, 1.55]

0.666

Day 6

0.66 [0.37, 0.95]

0.043

0.75 [0.15, 3.46]

0.710

0.67 [0.35, 0.86]

0.022

  1. Logistic regression models were fitted with the use of any, dopamine or epinephrine as the response variable and the treatment group as the independent variable. The models were stratified by the ICU days from 0 to 6. OR < 1 indicates lower requirement of vasopressors for the treated groups against the control group
Back to article page

Critical Care

ISSN: 1364-8535